Has Tanisha Mathur, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,109 in general payments to Tanisha Mathur, MD across 114 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tanisha Mathur, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tanisha Mathur, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tanisha Mathur, MD

Rheumatology · Columbus, OHNPI 1669634671

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.3% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $558, 2.3 times the $238 reported in 2019.

$2,109in general payments, 2019–2025

Across 114 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$467
Johnson & Johnson$320
UCB, Inc.$279
E.r. Squibb & Sons, L.L.C.$269
AbbVie$209
Novartis$184
plus $382 from 5 others

What the payments were for

Food & beverage$1,90490%
Education$20510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	31	$467
Johnson & Johnson	14	$320
UCB, Inc.	7	$279
E.r. Squibb & Sons, L.L.C.	23	$269
AbbVie	12	$209
Novartis	10	$184
Genentech USA, Inc.	5	$144
AstraZeneca	6	$126
ANI Pharmaceuticals, Inc.	3	$70
Lilly USA, LLC	2	$27
Celltrion USA Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Bimzelx$119
Rituxan$100
Actemra$100

How this compares

$2,109 in reported general payments places this provider in the 55th percentile of 255 rheumatology providers in Ohio.

See all rheumatology providers in Ohio →

Medicare billing

Part B allowed, 2024

$93,509

Medicare patients

Services billed

4,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	12	$81,770
Hydroxychloroquine Sulfate	132	$4,872
Colchicine	64	$4,716
Mycophenolate Mofetil	32	$3,545
MethotrexateMethotrexate Sodium	131	$3,151
Febuxostat	20	$2,404
Leflunomide	31	$1,868
Etodolac	13	$1,053
Prednisone	95	$812
Gabapentin	39	$738
Pregabalin	16	$465
Sulfasalazine	15	$355
Duloxetine Hcl	32	$315
Tizanidine Hcl	43	$303
Allopurinol	37	$289

Paid to pharmacies, not to this prescriber.

Other rheumatology in Columbus

Alexa MearaColumbus$426K
Kevin SchlesselColumbus$63K
Jacob SeymourColumbus$27K
Ali AjamColumbus$24K
Heather LakeColumbus$13K
Matthew MundwilerColumbus$11K
Marc AntonchakColumbus$10K
Leonard CalabreseCleveland$1.9M
Gregory DelorenzoCincinnati$1.3M
Chad DealCleveland$375K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →